Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
DOACs in patients with brain cancers: promising but still a long way to go — Michela Giustozzi (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
DOACs in patients with brain cancers: promising but still a long way to go
Shared by
Giancarlo Agnelli
University of Perugia
DOACs in patients with brain cancers: promising but still a long way to go
Letter
2022
en
Authors
+2 more
MG
Michela Giustozzi
CB
Cecilia Becattini
FR
Fausto Roila
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2019
Prevention of Biliary Cancer With Statins: Still a Long Way to Go
Massimo Colombo
,
Federica Turati
,
Carlo La Vecchia
Letter
2016
Promising, but still a matter of debate
Yohei Sotomi
,
Patrick W. Serruys
Catheterization and Cardiovascular Interventions
Letter
2021
Risk Scores for Death in Patients with Cancer-related Venous Thromboembolism: Still a Long Road Ahead
Daniele Pastori
,
Giancarlo Agnelli
Article
2018
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study
Maria Cristina Vedovati
,
Michela Giustozzi
,
Paolo Verdecchia
,
Lucia Pierpaoli
,
Serenella Conti
,
Melina Verso
,
Francesco Di Filippo
,
Emanuela Marchesini
,
Giulio Bogliari
,
Giancarlo Agnelli
,
Cecilia Becattini
Article
2021
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study
Tze‐Fan Chao
,
Yi‐Hsin Chan
,
Ta‐Chuan Tuan
,
Jo‐Nan Liao
,
Tzeng‐Ji Chen
,
Professor Gregory Lip
,
Shih‐Ann Chen
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.